Combination therapy with immune check point inhibitors and acute kidney injury.
Amalie ValentinAnne Kirstine Hundahl MøllerJesper Andreas PalshofBo BrobergEva GravesenInge Marie SvaneDitte HansenPublished in: Acta oncologica (Stockholm, Sweden) (2023)
Patients receiving combination therapy with checkpoint inhibitors are at high risk of AKI, but different causes of AKI should always be considered. Use of PPI concurrently with ICIs is likely to increase the risk of AKI.